Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1975-04-22
1977-12-13
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424195, A61K 3170, A61K 3578
Patent
active
040629490
ABSTRACT:
A pharmaceutical composition comprising abrin and nucleic acid wherein the ratio of abrin to nucleic acid is about 1:40 by weight is provided. The composition has less toxicity than abrin alone.
REFERENCES:
dyer, An Index of Tumor Chemotherapy, N.I.H., Mar. 1949, pp. 10-12, 145, 146 and 175.
Lin Jung-Yaw
Tung Ta-Cheng
Eisai Co. Ltd.
Goldberg Jerome D.
LandOfFree
Abrin composition of reduced toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Abrin composition of reduced toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abrin composition of reduced toxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-489428